flymetothemoon2
Nov 16, 7:30 PM
$ABCL
AbCellera’s Q3 slides on ABCL635 report complete resolution of VMS symptoms in 37 percent of participants, versus 2 percent on placebo. Stopping the symptom entirely, not just softening it, is a different bar to clear.
Dare I say it…? Carl’s words not mine…
0 replies